YourPath provides medication-assisted treatment (MAT) using buprenorphine to support individuals recovering from opioid use disorders. The startup enhances access to care through its telehealth platform, offering no-cost comprehensive assessments and ongoing support from peers and clinicians.
Funding
$4.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Individuals recovering from opioid use disorders often face barriers to accessing medication-assisted treatment (MAT) due to limited clinic availability, transportation challenges, and stigma associated with in-person treatment. Traditional MAT programs may also lack comprehensive support services, leading to higher relapse rates.
Solution
YourPath provides accessible and comprehensive medication-assisted treatment (MAT) for opioid use disorders through a telehealth platform called Sala. The platform offers no-cost comprehensive assessments, connecting individuals with medical providers for buprenorphine prescriptions and ongoing support. Patients can engage with peers and clinicians remotely, receiving personalized care and guidance throughout their recovery journey. By leveraging telehealth, YourPath removes geographical barriers and expands access to evidence-based treatment and support services.
Target Audience
The primary target audience includes individuals seeking recovery from opioid use disorders, particularly those who face barriers to accessing traditional in-person treatment options.
Features
- Telehealth platform (Sala) for remote access to MAT services
- No-cost comprehensive assessments to determine individual needs
- Prescription and management of buprenorphine (Suboxone)
- Ongoing support from peers and clinicians via text and chat
- Personalized care plans tailored to individual recovery goals